 Janus Henderson Group PLC grew its position in shares of Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 0.6 during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The firm owned 491,691 shares of the companys stock after buying an additional 2,819 shares during the quarter. Janus Henderson Group ... 